ArticleAesthetic plastic surgery2026
Two Surgeons Are Faster than One: A Comparative Study to Evaluate Efficiency and Outcomes in Reduction Mammaplasty.
Article in Aesthetic plastic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe increasing demand for reduction mammaplasty has heightened the need for cost-effective and efficient surgical practices. Evidence from other surgical fields suggests that co-surgeon teams can improve operative efficiency. AIMS AND
objectivesThis study aimed to compare operative time and outcomes in reduction mammaplasty performed by co-surgeons (CS) versus a single surgeon (SS). MATERIALS AND
methodsWe conducted a retrospective cohort study including all consecutive patients who underwent primary reduction mammaplasty in a 20-years period. All procedures were led by attending faculty surgeons, with assistants being either residents or other attendings. The primary outcome was operative time; secondary outcomes included intraoperative blood loss; resection weight, postoperative complications, reoperations, and length of hospital stay.
resultsA total of 1716 patients were included: 855 (49.8%) underwent surgery with a SS, and 861 (50.2%) with a CS. Demographic and comorbidity profiles were mostly similar across the groups. Operative time was significantly shorter in the CS group (119.6 vs. 136.1 minutes, p < 0.001). Postoperative complication rates and early reoperations were similar between groups. However, CS cases had a longer mean hospital stay (0.6 vs. 0.4 days, p < 0.001). Late reoperations (>30 days post-op), particularly for dog-ear corrections were more common in the CS group (11.7 vs. 3.0%, p < 0.001). Multivariate analysis showed that higher BMI and smoking were significant predictors of complication occurrence.
conclusionUsing co-surgeons in reduction mammaplasty significantly reduces operative time. However, it may be associated with longer hospital stay and increased long-term reoperation rates. Further studies are needed to evaluate the cost-benefit ratio of this approach. LEVEL OF EVIDENCE III: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.